Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 09, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With Myelofibrosis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 08, 2025
Impact of body mass index on outcomes following allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: March 24, 2025
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines.
Journal: Bone marrow transplantation
Published: December 19, 2024
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis.
Journal: Hematology, transfusion and cell therapy
Published: October 03, 2024
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: September 20, 2023
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Journal: Leukemia & lymphoma
Published: August 14, 2023
Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review.
Journal: Hematology/oncology and stem cell therapy
Published: July 12, 2023
Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: June 23, 2023
Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: January 27, 2023
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.
Journal: Leukemia & lymphoma
Published: October 25, 2022
Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 18, 2022
Last Updated: 09/26/2026